SIC 2834 – Pharmaceutical Preparations
Valuation | |
---|---|
Market Cap ($M) | 7,512.69 |
Enterprise Value ($M) | 11,406.36 |
Book Value ($M) | 4,171.07 |
Book Value / Share | 69.00 |
Price / Book | 1.80 |
NCAV ($M) | -3,694.23 |
NCAV / Share | -61.11 |
Price / NCAV | -2.03 |
Profitability (mra) | |
---|---|
Return on Invested Capital (ROIC) | 0.04 |
Return on Assets (ROA) | 0.04 |
Return on Equity (ROE) | 0.13 |
Liquidity (mrq) | |
---|---|
Quick Ratio | 3.74 |
Current Ratio | 4.26 |
Balance Sheet (mrq) ($M) | |
---|---|
Current Assets | 4,390.42 |
Assets | 12,255.72 |
Liabilities | 8,084.65 |
Debt | n/a |
Equity | n/a |
Income Statement (mra) ($M) | |
---|---|
Revenue | 0.00 |
Operating Income | 0.00 |
Net Income | 0.00 |
Earnings Per Share Diluted | n/a |
Earnings Per Share Basic | n/a |
Cash Flow Statement (mra) ($M) | |
---|---|
Cash From Operations | 0.00 |
Cash from Investing | 0.00 |
Cash from Financing | 0.00 |
(click for more detail) |
File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
---|---|---|---|---|
13G/A | Vanguard Group Inc | 10.11 | -1.79 | |
13G/A | BlackRock, Inc. | 11.20 | 6.06 |
Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
---|---|---|---|---|
(click for more detail) |
Date | Insider Trades | Code | Shares | Value |
---|---|---|---|---|
(click for more detail) |
File Date | Form | SEC Filings |
---|---|---|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K | ||
(click for more detail) |
Short Volume | |||
---|---|---|---|
Market Date | Short Volume | Total Volume | Short Volume Ratio |
150,594 | 586,397 | 25.68 | |
182,473 | 708,525 | 25.75 | |
231,918 | 737,654 | 31.44 | |
189,277 | 788,869 | 23.99 | |
224,613 | 872,542 | 25.74 | |
(click for more detail) |
Similar Companies | |
---|---|
IPSC – Century Therapeutics, Inc. | IRWD – Ironwood Pharmaceuticals, Inc. |
ITCI – Intra-Cellular Therapies, Inc. | KMDA – Kamada Ltd. |
KNSA – Kiniksa Pharmaceuticals, Ltd. |
Financial data and stock pages provided by
Fintel.io